Neogen Stock Current Valuation
| NEOG Stock | USD 5.58 0.05 0.89% |
Valuation analysis of Neogen helps investors to measure Neogen's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The Neogen's current Enterprise Value is estimated to increase to about 3.4 B, while Enterprise Value Over EBITDA is projected to decrease to 16.26. Fundamental drivers impacting Neogen's valuation include:
Undervalued
Today
Please note that Neogen's price fluctuation is slightly risky at this time. Calculation of the real value of Neogen is based on 3 months time horizon. Increasing Neogen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Neogen stock is determined by what a typical buyer is willing to pay for full or partial control of Neogen. Since Neogen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Neogen Stock. However, Neogen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.58 | Real 8.07 | Target 15.75 | Hype 5.59 |
The real value of Neogen Stock, also known as its intrinsic value, is the underlying worth of Neogen Company, which is reflected in its stock price. It is based on Neogen's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Neogen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Neogen helps investors to forecast how Neogen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Neogen more accurately as focusing exclusively on Neogen's fundamentals will not take into account other important factors: Neogen Company Current Valuation Analysis
Neogen's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Neogen Current Valuation | 1.98 B |
Most of Neogen's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Neogen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Neogen Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Neogen is extremely important. It helps to project a fair market value of Neogen Stock properly, considering its historical fundamentals such as Current Valuation. Since Neogen's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Neogen's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Neogen's interrelated accounts and indicators.
Click cells to compare fundamentals
Neogen Current Valuation Historical Pattern
Today, most investors in Neogen Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Neogen's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Neogen current valuation as a starting point in their analysis.
Neogen Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Neogen has a Current Valuation of 1.98 B. This is 86.24% lower than that of the Health Care Equipment & Supplies sector and 74.65% lower than that of the Health Care industry. The current valuation for all United States stocks is 88.11% higher than that of the company.
Neogen Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Neogen's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Neogen could also be used in its relative valuation, which is a method of valuing Neogen by comparing valuation metrics of similar companies.Neogen is currently under evaluation in current valuation category among its peers.
Neogen ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Neogen's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Neogen's managers, analysts, and investors.Environmental | Governance | Social |
Neogen Fundamentals
| Return On Equity | -0.16 | ||||
| Return On Asset | 0.0068 | ||||
| Profit Margin | (0.52) % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 1.98 B | ||||
| Shares Outstanding | 217.04 M | ||||
| Shares Owned By Insiders | 0.27 % | ||||
| Shares Owned By Institutions | 99.73 % | ||||
| Number Of Shares Shorted | 26.22 M | ||||
| Price To Earning | 13.36 X | ||||
| Price To Book | 0.46 X | ||||
| Price To Sales | 1.33 X | ||||
| Revenue | 924.22 M | ||||
| Gross Profit | 448.62 M | ||||
| EBITDA | 182.6 M | ||||
| Net Income | (9.42 M) | ||||
| Cash And Equivalents | 347.71 M | ||||
| Cash Per Share | 3.22 X | ||||
| Total Debt | 906.24 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 9.07 X | ||||
| Book Value Per Share | 12.26 X | ||||
| Cash Flow From Operations | 35.26 M | ||||
| Short Ratio | 9.45 X | ||||
| Earnings Per Share | (2.23) X | ||||
| Price To Earnings To Growth | 0.66 X | ||||
| Target Price | 13.0 | ||||
| Number Of Employees | 2.92 K | ||||
| Beta | 1.57 | ||||
| Market Capitalization | 1.21 B | ||||
| Total Asset | 4.55 B | ||||
| Retained Earnings | 555.62 M | ||||
| Working Capital | 434.91 M | ||||
| Current Asset | 250 M | ||||
| Current Liabilities | 28.6 M | ||||
| Net Asset | 4.55 B |
About Neogen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Neogen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Neogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Neogen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Neogen is a strong investment it is important to analyze Neogen's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neogen's future performance. For an informed investment choice regarding Neogen Stock, refer to the following important reports:Check out Neogen Piotroski F Score and Neogen Altman Z Score analysis. For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neogen. If investors know Neogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.86) | Earnings Share (2.23) | Revenue Per Share | Quarterly Revenue Growth 0.007 | Return On Assets |
The market value of Neogen is measured differently than its book value, which is the value of Neogen that is recorded on the company's balance sheet. Investors also form their own opinion of Neogen's value that differs from its market value or its book value, called intrinsic value, which is Neogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neogen's market value can be influenced by many factors that don't directly affect Neogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.